Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_notes_note in Note (approximate match)

Showing 6781 - 6790 of 6878 results

First page
Previous page
Next page
Next page

NADROPARIN CALCIUM

LIA7Z4002P

Status:

Possibly Marketed Outside US

Source:

NCT02630095: Phase 4 Interventional Unknown status Portal Vein Thrombosis

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02630095

Class:

POLYMER

REVIPARIN SODIUM

5XQ9UBJ16W

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:B01AB08

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/5R0L1D739E

Class:

POLYMER

PARNAPARIN SODIUM

U6K360XMIU

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:B01AB07

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/M316WT19D8

Class:

POLYMER

CERTOPARIN SODIUM

N816FF9P2W

Status:

Possibly Marketed Outside US

Source:

NCT00196417: Phase 4 Interventional Unknown status Heparin-Induced Thrombocytopenia

(2003)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00196417

Class:

POLYMER

COLESTILAN CHLORIDE

VSI302RYSR

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:V03AE06

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/VSI302RYSR

Class:

POLYMER

INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

2J002Y0B0W

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

P8ORN3UOM6

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2015

Source:

BLA125510

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

3NZW5ND3D6

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

XW4JB03TI5

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2009

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/HONG KONG/2671/2019 NIB-121 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

08R56E092Z

Status:

US Approved Rx (2016)

Source:

BLA125285

(2016)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2007

Source:

BLA125254

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

Structure of NADROPARIN CALCIUM

Polymer

NADROPARIN CALCIUM

Structure of REVIPARIN SODIUM

Polymer

REVIPARIN SODIUM

Structure of PARNAPARIN SODIUM

Polymer

PARNAPARIN SODIUM

Structure of CERTOPARIN SODIUM

Polymer

CERTOPARIN SODIUM

Structure of COLESTILAN CHLORIDE

Polymer

COLESTILAN CHLORIDE

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/HONG KONG/2671/2019 NIB-121 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Showing 6781 - 6790 of 6878 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1